Biacore System Used in Study to Show Potential Drug Target for Sleeping Sickness Causing Parasites

GE Healthcare, a unit of General Electric Company (NYSE: GE), announced today that a Biacore™ system played a key role in the discovery of a drug target for the sleeping sickness parasite T. brucei (subsp. rhodesiense and gambiense). The paper was published in Science, May 2008; 320: 677 – 681 and is the result of a collaboration between scientists at the Université Libre de Bruxelles, Belgium, and the University of Aarhus, Denmark.

Source: GE Healthcare